Talk:Supracompetitive pricing

Economics Low‑importance

	Business and economics portal This article is within the scope of WikiProject Economics, a collaborative effort to improve the coverage of Economics on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.EconomicsWikipedia:WikiProject EconomicsTemplate:WikiProject EconomicsEconomics articles
Low	This article has been rated as Low-importance on the project's importance scale.

Marketing & Advertising Mid‑importance

	This article is within the scope of WikiProject Marketing & Advertising, a collaborative effort to improve the coverage of Marketing on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Marketing & AdvertisingWikipedia:WikiProject Marketing & AdvertisingTemplate:WikiProject Marketing & AdvertisingMarketing & Advertising articles
Mid	This article has been rated as Mid-importance on the importance scale.

Complaint

I disagree with this entire article.

Drugs companies (and I work well down the company chain in them) invest BILLIONS to develop a drug, their patent expires depending on the jurisdiction in seven or twelve years in which they have to recoup their money for their investment in the innovation. You can argue that yes or no but it is a supremely bad example and seems to me forced. Since in my life I have worked for drugs companies, defence (i.e. war) companies, and all kinds of other stuff I know my stuff here. It is HARD. If you don't want your nice drugs on you tabletop don't have them. So I think this is vaguely not NPOV (though it is so written) I think we need a less controversial example, at least to lead it as we develop tghe article-- then we can shove it in a section.

Nothing you have said is untrue, but I think biased.

SimonTrew (talk) 06:34, 12 February 2009 (UTC)[reply]

hello. im daisy, —Preceding unsigned comment added by 80.176.254.64 (talk) 10:55, 3 March 2009 (UTC)[reply]